What is the recommended dosage and treatment duration for Lansoprazole (proton pump inhibitor) in treating conditions like Gastroesophageal Reflux Disease (GERD) and Helicobacter pylori infection?

Lansoprazole Dosing and Treatment Duration

GERD Treatment

For adults with GERD, lansoprazole 30 mg once daily taken 30-60 minutes before breakfast is the standard initial dose, with escalation to twice-daily dosing if symptoms persist after 4-8 weeks of once-daily therapy. 1

Adult Dosing for GERD

• Initial therapy: 30 mg once daily for symptomatic GERD (up to 8 weeks) 2
• Erosive esophagitis: 30 mg once daily for 8 weeks; if unhealed, an additional 8-week course may be given 2
• Maintenance therapy: 15-30 mg daily to maintain healing of erosive esophagitis (studied up to 12 months) 2, 3
• Timing: Administer 30-60 minutes before a meal for optimal efficacy 1, 4

Pediatric GERD Dosing

• Weight-based dosing: 0.7-3 mg/kg/day for children ages 1-17 years 1
• Treatment duration: Up to 8 weeks for ages 12-17 years; up to 12 weeks for ages 1-11 years 2
• Formulation options: Capsule contents can be sprinkled on soft foods, administered in juice via nasogastric tube, or given as orally disintegrating tablets 1

Refractory GERD Management

• If once-daily PPI therapy fails, escalate to twice-daily dosing (30 mg before breakfast and dinner) before considering treatment failure 1
• After failure of twice-daily PPI therapy for 4-8 weeks, proceed to endoscopy rather than further empiric dose escalation 1

Helicobacter pylori Eradication

For H. pylori eradication, lansoprazole 30 mg twice daily (before morning and evening meals) combined with antibiotics for 10-14 days achieves optimal eradication rates, with 60 mg twice daily showing superior efficacy in some studies. 1, 5

Triple Therapy Regimens

• Lansoprazole + amoxicillin + clarithromycin: 30 mg lansoprazole twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily for 10-14 days 2, 1
• Duration: 10-14 days is recommended; 10-day therapy appears more effective than 7-day therapy 5, 1
• Higher-dose option: Lansoprazole 60 mg twice daily with antibiotics significantly improves eradication rates (87-92% vs. 76-80% with 30 mg) 5

Dual Therapy (Clarithromycin-Allergic Patients)

• Lansoprazole + amoxicillin: 30 mg lansoprazole three times daily with amoxicillin 1 g three times daily for 14 days 2
• This regimen is indicated only for patients allergic/intolerant to clarithromycin or with known clarithromycin resistance 2

Alternative Regimens for Refractory H. pylori

• Bismuth quadruple therapy: Bismuth subsalicylate, tetracycline 500 mg four times daily, metronidazole 500 mg three-four times daily, plus lansoprazole 30-40 mg twice daily for 14 days 1
• Rifabutin triple therapy: Rifabutin 150 mg twice daily, amoxicillin 1 g twice daily, lansoprazole 40 mg twice daily for 10-14 days 1
• After two failed eradication attempts, susceptibility testing should guide subsequent therapy 1

Other Indications

Peptic Ulcer Disease

• Duodenal ulcer: 15 mg once daily for 4 weeks (healing); 15 mg once daily for maintenance (up to 12 months) 2
• Gastric ulcer: 30 mg once daily for up to 8 weeks 2
• NSAID-associated gastric ulcer: 30 mg once daily for 8 weeks (treatment); 15 mg once daily for up to 12 weeks (prevention in high-risk patients) 2

Hypersecretory Conditions

• Zollinger-Ellison syndrome: Initial dose 60 mg once daily; titrate to individual patient needs; doses up to 90 mg twice daily have been used 2, 6

Critical Dosing Considerations

PPI Potency Equivalence

• Lansoprazole 30 mg ≈ omeprazole 27 mg ≈ esomeprazole 20 mg ≈ rabeprazole 20 mg 1
• For H. pylori eradication, higher-potency PPIs (esomeprazole or rabeprazole 20-40 mg twice daily) may be preferred over lansoprazole when cost is equivalent 1
• Pantoprazole should be avoided in amoxicillin-containing regimens due to lower relative potency 1

Common Pitfalls

• Inadequate dosing duration: Many treatment failures result from stopping therapy too early; complete the full course even if symptoms resolve 1
• Incorrect timing: Taking lansoprazole with meals or without adequate pre-meal interval reduces efficacy 1, 4
• Premature escalation: Endoscopy is not indicated until after documented failure of twice-daily PPI therapy for 4-8 weeks 1
• Tachyphylaxis with H2RAs: Do not add nighttime H2-receptor antagonists to twice-daily PPI therapy; this combination lacks evidence of benefit 1